🇺🇸 FDA
Pipeline program

Colquhounia Root Tablet

2022-001P6A01

Approved small_molecule active

Quick answer

Colquhounia Root Tablet for Rheumatoid Arthritis is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Rheumatoid Arthritis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials